Sun Pharma reports 54% fall in Q4 consolidated net profit

29 May 2019 Evaluate

Sun Pharmaceutical Industries has reported results for fourth quarter and year ended March 31, 2019.

The company has reported a 2-fold jump in its net profit at Rs 1068.06 crore for the quarter under review as compared to Rs 504.62 crore for the same quarter in the previous year. Total income of the company increased by 13.07% at Rs 3,231.36 crore for Q4FY19 as compared Rs 2,857.77 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 54.41% in its net profit at Rs 723.05 crore for the quarter under review as compared to Rs 1,585.85 crore for the same quarter in the previous year. However, total income of the company marginally increased by 2.27% at Rs 7,445.45 crore for Q4FY19 as compared Rs 7,279.85 crore for the corresponding quarter previous year.

For the year ended March 31, 2019, the company has reported around 3-fold jump in its net profit at Rs 816.60 crore as compared to Rs 305.64 crore for the previous year. Total income of the company increased by 14.21% at Rs 11,574.65 crore for year under review as compared to Rs 10,134.29 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has reported a rise of 24.98% in its net profit at Rs 3,209.32 crore as compared to Rs 2,567.94 crore for the previous year. Total income of the company increased by 10.11% at Rs 30,091.40 crore for year under review as compared to Rs 27,328.22 crore for year ended March 31, 2018.

Sun Pharma Inds. Share Price

1700.55 -29.25 (-1.69%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×